Skip to main content
Erschienen in: Zeitschrift für Gerontologie und Geriatrie 1/2012

01.01.2012 | CME Weiterbildung · Zertifizierte Fortbildung

Management und Therapie des Vorhofflimmerns beim geriatrischen Patienten

verfasst von: Mag. Dr. M. Gosch, MAS, R.E. Roller, B. Böhmdorfer, U. Benvenuti-Falger, B. Iglseder, M. Lechleitner, U. Sommeregger, P. Dovjak

Erschienen in: Zeitschrift für Gerontologie und Geriatrie | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Zusammenfassung

Vorhofflimmern ist die häufigste Herzrhythmusstörung bei geriatrischen Patienten, die Prävalenz bei über 80-Jährigen beträgt etwa 10%. Patienten mit Vorhofflimmern haben ein doppelt so hohes Mortalitätsrisiko, das Risiko für einen Schlaganfall ist um den Faktor 5 erhöht. Im Gegensatz dazu stehen die aktuellen Leitlinien der Europäischen Kardiologischen Gesellschaft (ESC), die diese Patientengruppe kaum berücksichtigen. Insbesondere mangelt es an Empfehlungen zu alltäglichen Fragen in der klinischen Betreuung dieser Patientengruppe. Ziel der vorliegenden Arbeit ist, für geriatrisch tätige Kolleg(inn)en unter Aufarbeitung der spezifischen Fachliteratur die vorliegende europäische Leitlinie für dieses Patientenkollektiv zu ergänzen. Diskutiert werden die Themenbereiche Rhythmus- versus Frequenzkontrolle, Antikoagulation, Outcome und Prävention, Stürze, Compliance/Adhärenz, Polypharmazie, geriatrisches Assessment, Demenz, Pflegeheimpatienten und Frailty nach Literaturrecherche in PubMed in Hinblick auf den geriatrischen Patienten. Individuelle Aspekte sollten in die Therapiegestaltung einfließen, allerdings darf die Komplexität dieser Patienten nicht zu einer bedingungslosen Individualisierung der Therapie abseits der Leitlinien führen. Denn es gibt zahlreiche Literaturstellen, mit denen sich viele offene Fragen im Zusammenhang mit Vorhofflimmern bei geriatrischen Patienten beantworten lassen.
Literatur
1.
Zurück zum Zitat Go AS, Hylek EM, Phillips KA et al (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285:2370–2375PubMedCrossRef Go AS, Hylek EM, Phillips KA et al (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285:2370–2375PubMedCrossRef
2.
Zurück zum Zitat Fetsch T, Bauer P, Engberding R et al (2004) Prevention of atrial fibrillation after cardioversion investigators. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial. Eur Heart J 25:1385–1394PubMedCrossRef Fetsch T, Bauer P, Engberding R et al (2004) Prevention of atrial fibrillation after cardioversion investigators. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial. Eur Heart J 25:1385–1394PubMedCrossRef
3.
Zurück zum Zitat Lloyd-Jones DM, Wang TJ, Leip EP et al (2004) Lifetime risk for development of atrial fibrillation: the Framingham Heart study. Circulation 110:1042–1046PubMedCrossRef Lloyd-Jones DM, Wang TJ, Leip EP et al (2004) Lifetime risk for development of atrial fibrillation: the Framingham Heart study. Circulation 110:1042–1046PubMedCrossRef
4.
Zurück zum Zitat Maisel WH, Stevenson LW (2003) Atrial fibrillation in heart failure: epidemiology, pathophysiology and rationale for therapy. Am J Cardiol 91(6A):2D–8DPubMedCrossRef Maisel WH, Stevenson LW (2003) Atrial fibrillation in heart failure: epidemiology, pathophysiology and rationale for therapy. Am J Cardiol 91(6A):2D–8DPubMedCrossRef
5.
Zurück zum Zitat Benjamin EJ, Levy D, Vaziri SM et al (1994.) Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 271:840–844PubMedCrossRef Benjamin EJ, Levy D, Vaziri SM et al (1994.) Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 271:840–844PubMedCrossRef
6.
Zurück zum Zitat Friberg L, Hammar N, Rosenqvist M (2010) Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort a trial fibrillation. Eur Heart J 31:967–975PubMedCrossRef Friberg L, Hammar N, Rosenqvist M (2010) Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort a trial fibrillation. Eur Heart J 31:967–975PubMedCrossRef
7.
Zurück zum Zitat Knecht S, Oelschlager C, Duning T et al (2008) A trial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy. Eur Heart J 29:2125–2132PubMedCrossRef Knecht S, Oelschlager C, Duning T et al (2008) A trial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy. Eur Heart J 29:2125–2132PubMedCrossRef
8.
Zurück zum Zitat Thrall G, Lane G, Caroll D et al (2006) Quality of life in patients with atrial fibrillation: a systematic review. Am J Med 119:448, e1–e19PubMedCrossRef Thrall G, Lane G, Caroll D et al (2006) Quality of life in patients with atrial fibrillation: a systematic review. Am J Med 119:448, e1–e19PubMedCrossRef
9.
Zurück zum Zitat Camm AJ, Kirchhof P, Lip GY et al (2010) Guidelines for the management of a trial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31:2369–2429PubMedCrossRef Camm AJ, Kirchhof P, Lip GY et al (2010) Guidelines for the management of a trial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31:2369–2429PubMedCrossRef
10.
Zurück zum Zitat Wheeler R, Masani ND (2011) The role of echocardiography in the management of atrial fibrillation. Eur J Echocardiogr 12:i33–i38PubMedCrossRef Wheeler R, Masani ND (2011) The role of echocardiography in the management of atrial fibrillation. Eur J Echocardiogr 12:i33–i38PubMedCrossRef
11.
Zurück zum Zitat Wyse DG (2009) Pharmacotherapy for rhythm management in elderly patients with atrial fibrillation. J Interv Card Electrophysiol 25:25–29PubMedCrossRef Wyse DG (2009) Pharmacotherapy for rhythm management in elderly patients with atrial fibrillation. J Interv Card Electrophysiol 25:25–29PubMedCrossRef
12.
Zurück zum Zitat Fauchier L, Grimard C, Pierre B et al (2009) Comparison of beta blocker and digoxin alone and in combination for management of patients with atrial fibrillation and heart failure. Am J Cardiol 103:248–254PubMedCrossRef Fauchier L, Grimard C, Pierre B et al (2009) Comparison of beta blocker and digoxin alone and in combination for management of patients with atrial fibrillation and heart failure. Am J Cardiol 103:248–254PubMedCrossRef
13.
Zurück zum Zitat Woolcott JC, Richardson KJ, Wiens MO et al (2009) Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 169(21):1952–1960PubMedCrossRef Woolcott JC, Richardson KJ, Wiens MO et al (2009) Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 169(21):1952–1960PubMedCrossRef
14.
Zurück zum Zitat Hohnloser SH, Crijns HJGM, Eickels M van for the ATHENA Investigators et al (2009) Effect for dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med 360:668–678PubMedCrossRef Hohnloser SH, Crijns HJGM, Eickels M van for the ATHENA Investigators et al (2009) Effect for dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med 360:668–678PubMedCrossRef
15.
Zurück zum Zitat Deaths doubled with dronedarone in PALLAS: FDA and EMA updates. http://www.theheart.org/article/1255799.do. Zugegriffen: 26.10.2011 Deaths doubled with dronedarone in PALLAS: FDA and EMA updates. http://​www.​theheart.​org/​article/​1255799.​do.​ Zugegriffen: 26.10.2011
16.
Zurück zum Zitat Vidaillet HJ (2005) Rate control vs. rhythm control in the management of atrial fibrillation in elderly persons. Am J Geriatr Cardiol 14(2):73–78PubMedCrossRef Vidaillet HJ (2005) Rate control vs. rhythm control in the management of atrial fibrillation in elderly persons. Am J Geriatr Cardiol 14(2):73–78PubMedCrossRef
17.
Zurück zum Zitat Roy D, Talajic M, Nattel S et al (2008) Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 358(25):2667–2677PubMedCrossRef Roy D, Talajic M, Nattel S et al (2008) Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 358(25):2667–2677PubMedCrossRef
18.
Zurück zum Zitat Waldo AL (2009) Anticoagulation: stroke prevention in patients with atrial fibrillation. Cardiol Clin 27:125–135PubMedCrossRef Waldo AL (2009) Anticoagulation: stroke prevention in patients with atrial fibrillation. Cardiol Clin 27:125–135PubMedCrossRef
19.
Zurück zum Zitat Mant J, Hobbs FD, Fletcher K et al (2007) Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomized controlled trial. Lancet 370:493–503PubMedCrossRef Mant J, Hobbs FD, Fletcher K et al (2007) Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomized controlled trial. Lancet 370:493–503PubMedCrossRef
20.
Zurück zum Zitat Ortiz RM, Romo E, Mesa D et al (2011) Outcomes and safety of antithrombotic treatment in patients aged over 80 years or older with nonvalvular atrial fibrillation. Am J Cardiol (Epub ahead of print) Ortiz RM, Romo E, Mesa D et al (2011) Outcomes and safety of antithrombotic treatment in patients aged over 80 years or older with nonvalvular atrial fibrillation. Am J Cardiol (Epub ahead of print)
21.
Zurück zum Zitat Benavente L, Calleja S, Vega V de la et al (2010) Oral anticoagulation in elderly patients as secondary prevention of cardioembolic stroke. Int Arch Med 3:8PubMedCrossRef Benavente L, Calleja S, Vega V de la et al (2010) Oral anticoagulation in elderly patients as secondary prevention of cardioembolic stroke. Int Arch Med 3:8PubMedCrossRef
22.
Zurück zum Zitat Pugh D, Pugh J, Mead GE (2011) Attitudes of physicians regarding anticoagulation for atrial fibrillation: a systematic review. Age Ageing 0:1–9 Pugh D, Pugh J, Mead GE (2011) Attitudes of physicians regarding anticoagulation for atrial fibrillation: a systematic review. Age Ageing 0:1–9
23.
Zurück zum Zitat Connolly SJ, Ezekowitz MD, Phil CHB et al (2009) Dabigatran versus Warfarin in patients with atrial fibrillation. N Engl J Med 361:1139–1150PubMedCrossRef Connolly SJ, Ezekowitz MD, Phil CHB et al (2009) Dabigatran versus Warfarin in patients with atrial fibrillation. N Engl J Med 361:1139–1150PubMedCrossRef
24.
Zurück zum Zitat Connolly SJ, Eikelboom J, Campbell Joyner BS et al (2011) Apixaban in patients with atrial fibrillation. N Engl J Med 364:806–817PubMedCrossRef Connolly SJ, Eikelboom J, Campbell Joyner BS et al (2011) Apixaban in patients with atrial fibrillation. N Engl J Med 364:806–817PubMedCrossRef
25.
Zurück zum Zitat Patel MR, Mahaffey KW, Garg J et al (2011) Rivaroxban versus Warfarin in nonvalvular atrial fibrillation. N Engl J Med 365(10):883–891PubMedCrossRef Patel MR, Mahaffey KW, Garg J et al (2011) Rivaroxban versus Warfarin in nonvalvular atrial fibrillation. N Engl J Med 365(10):883–891PubMedCrossRef
26.
Zurück zum Zitat Tabereux PB, Brass LM, Concato J et al (2008) Hospital admissions for stroke among very old in the USA. Neuroepidemiology 31:93–99CrossRef Tabereux PB, Brass LM, Concato J et al (2008) Hospital admissions for stroke among very old in the USA. Neuroepidemiology 31:93–99CrossRef
27.
Zurück zum Zitat Saposnik G, Black S (2009) Stroke in the very elderly: hospital care, case fatality and disposition. Cerebrovasc Dis 27:537–543PubMedCrossRef Saposnik G, Black S (2009) Stroke in the very elderly: hospital care, case fatality and disposition. Cerebrovasc Dis 27:537–543PubMedCrossRef
28.
Zurück zum Zitat Kammersgrd LP, Jörgensen HS, Reith J et al (2004) Short- and long-term prognosis for very old stroke patients. The Copenhagen Stroke study. Age Ageing 33:149–154CrossRef Kammersgrd LP, Jörgensen HS, Reith J et al (2004) Short- and long-term prognosis for very old stroke patients. The Copenhagen Stroke study. Age Ageing 33:149–154CrossRef
29.
Zurück zum Zitat Deplanque D, Leys D, Parnetti L et al (2004) Stroke prevention atrial fibrillation: reasons leading to an inappropriate management. Main results of the SAFE II study. Br J Clin Pharmacol 57(6):798–806PubMedCrossRef Deplanque D, Leys D, Parnetti L et al (2004) Stroke prevention atrial fibrillation: reasons leading to an inappropriate management. Main results of the SAFE II study. Br J Clin Pharmacol 57(6):798–806PubMedCrossRef
30.
Zurück zum Zitat Fang MC, Go AS, Hylek EM et al (2006) Age and risk of Warfarin-associated hemorrhage: the Anticoagulation and Risk Factors in Atrial Fibrillation study. JAGS 54:1231–1236CrossRef Fang MC, Go AS, Hylek EM et al (2006) Age and risk of Warfarin-associated hemorrhage: the Anticoagulation and Risk Factors in Atrial Fibrillation study. JAGS 54:1231–1236CrossRef
31.
Zurück zum Zitat Gage BF, Birman-Deych E, Kerzner R et al (2005) Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall. Am J Med 118:612–617PubMedCrossRef Gage BF, Birman-Deych E, Kerzner R et al (2005) Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall. Am J Med 118:612–617PubMedCrossRef
32.
Zurück zum Zitat Man-Son-Hing M, Nichol G, Lau A et al (1999) Choosing antithrombotic therapy for elderly patients with atrial fibrillation. Who are at risk for falls. Arch Intern Med 159:677–685PubMedCrossRef Man-Son-Hing M, Nichol G, Lau A et al (1999) Choosing antithrombotic therapy for elderly patients with atrial fibrillation. Who are at risk for falls. Arch Intern Med 159:677–685PubMedCrossRef
33.
Zurück zum Zitat Sellers MB, Newby LK (2011) Atrial fibrillation, anticoagulation, fall risk, and outcomes in elderly patients. Am Heart J 161:241–246PubMedCrossRef Sellers MB, Newby LK (2011) Atrial fibrillation, anticoagulation, fall risk, and outcomes in elderly patients. Am Heart J 161:241–246PubMedCrossRef
34.
Zurück zum Zitat Dossett LA, Riesel JN, Griffin MR et al (2011) Prevalence and implications of preinjury Warfarin use. Arch Surg 146(5):565–570PubMedCrossRef Dossett LA, Riesel JN, Griffin MR et al (2011) Prevalence and implications of preinjury Warfarin use. Arch Surg 146(5):565–570PubMedCrossRef
35.
Zurück zum Zitat Balkrishnan R (1998) Predictors of medication adherence in the elderly. Clin Ther 20:764–771PubMedCrossRef Balkrishnan R (1998) Predictors of medication adherence in the elderly. Clin Ther 20:764–771PubMedCrossRef
36.
Zurück zum Zitat Coons SJ, Shehan SL, Martin SS et al (1994) Predictors of medication noncompliance in a sample of older adults. Clin Ther 16:110–117PubMed Coons SJ, Shehan SL, Martin SS et al (1994) Predictors of medication noncompliance in a sample of older adults. Clin Ther 16:110–117PubMed
37.
Zurück zum Zitat Bardel A, Wallander MA, Svärdsudd K (2007) Factors associated with adherence to drug therapy: a population-based study. Eur J Pharmacol 63:307–314CrossRef Bardel A, Wallander MA, Svärdsudd K (2007) Factors associated with adherence to drug therapy: a population-based study. Eur J Pharmacol 63:307–314CrossRef
38.
Zurück zum Zitat Schüz B, Marx C, Wurm S et al (2011) Medication beliefs predict medication adherence in older adults with multiple illnesses. J Psychosom Res 70:179–187PubMedCrossRef Schüz B, Marx C, Wurm S et al (2011) Medication beliefs predict medication adherence in older adults with multiple illnesses. J Psychosom Res 70:179–187PubMedCrossRef
39.
Zurück zum Zitat Garner JB (2010) Problems of nonadherence in cardiology and proposals to improve oucome. Am J Cardiol 105:1495–1501PubMedCrossRef Garner JB (2010) Problems of nonadherence in cardiology and proposals to improve oucome. Am J Cardiol 105:1495–1501PubMedCrossRef
40.
Zurück zum Zitat Kneeland PP, Fang MC (2010) Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thomboembolism. Patient Prefer Adherence 4:51–60PubMed Kneeland PP, Fang MC (2010) Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thomboembolism. Patient Prefer Adherence 4:51–60PubMed
41.
Zurück zum Zitat Kimmel SE, Chen Z, Price M et al (2007) The influence of patient adherence on anticoagulation control with warfarin. Arch Intern Med 167:229–235PubMedCrossRef Kimmel SE, Chen Z, Price M et al (2007) The influence of patient adherence on anticoagulation control with warfarin. Arch Intern Med 167:229–235PubMedCrossRef
42.
Zurück zum Zitat Platt AB, Localio R, Brensinger CM et al (2008) Risk factors for nonadherence to warfarin: results from the IN-RANGE study. Pharmacoepidemiol Drug Saf 17(9):853–860PubMedCrossRef Platt AB, Localio R, Brensinger CM et al (2008) Risk factors for nonadherence to warfarin: results from the IN-RANGE study. Pharmacoepidemiol Drug Saf 17(9):853–860PubMedCrossRef
43.
Zurück zum Zitat Platt AB, Localio R, Brensinger CM et al (2010) Can we predict daily adherence to warfarin? Results from the IN-RANGE study. Chest 137(4):883–889PubMedCrossRef Platt AB, Localio R, Brensinger CM et al (2010) Can we predict daily adherence to warfarin? Results from the IN-RANGE study. Chest 137(4):883–889PubMedCrossRef
44.
Zurück zum Zitat Glasheen JJ, Fugit RV, Prochazka AV (2005) The risk of overanticoagulation with antidiotic use in outpatients on stable warfarin regimens. J Gen Intern Med 20:653–656PubMedCrossRef Glasheen JJ, Fugit RV, Prochazka AV (2005) The risk of overanticoagulation with antidiotic use in outpatients on stable warfarin regimens. J Gen Intern Med 20:653–656PubMedCrossRef
45.
Zurück zum Zitat Shorr RI, Ray WA, Daugherty JR et al (1993) Concurrent use of non-steroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease. Arch Intern Med 153:1665–1670PubMedCrossRef Shorr RI, Ray WA, Daugherty JR et al (1993) Concurrent use of non-steroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease. Arch Intern Med 153:1665–1670PubMedCrossRef
46.
Zurück zum Zitat Behr S (2010) Risk of intracerebral hemorrhage associated with phenprocoumon exposure: a nested case-control study in a large population-based German database. Pharmacoepidemiol Drug Saf 19:722–730PubMedCrossRef Behr S (2010) Risk of intracerebral hemorrhage associated with phenprocoumon exposure: a nested case-control study in a large population-based German database. Pharmacoepidemiol Drug Saf 19:722–730PubMedCrossRef
47.
Zurück zum Zitat Laine L, Smith R, Min K et al (2006) Systematic review: the lower gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 24:751–767PubMedCrossRef Laine L, Smith R, Min K et al (2006) Systematic review: the lower gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 24:751–767PubMedCrossRef
48.
Zurück zum Zitat Hanlon JT et al (1992) A method for assessing drug therapy appropriateness. J Clin Epidemiol 45(10):1045–1051PubMedCrossRef Hanlon JT et al (1992) A method for assessing drug therapy appropriateness. J Clin Epidemiol 45(10):1045–1051PubMedCrossRef
49.
Zurück zum Zitat Gallagher P et al (2008) STOPP (Screening tool of older person’s prescriptions) and START (Screening tool to alert doctors to right treatment). Consensus validation. Int J Clin Pharmacol Ther 46(2):72–83PubMed Gallagher P et al (2008) STOPP (Screening tool of older person’s prescriptions) and START (Screening tool to alert doctors to right treatment). Consensus validation. Int J Clin Pharmacol Ther 46(2):72–83PubMed
50.
Zurück zum Zitat Bunch TJ, Weiss JP, Crandell BG et al (2010) Atrial fibrillation is independently associated with senile, vascular, and Alzheimer’s dementia. Heart Rhythm 74(4):433–437CrossRef Bunch TJ, Weiss JP, Crandell BG et al (2010) Atrial fibrillation is independently associated with senile, vascular, and Alzheimer’s dementia. Heart Rhythm 74(4):433–437CrossRef
51.
Zurück zum Zitat Dublin S, Andrson ML, Haneuse SJ et al (2011) Atrial fibrillation and risk of dementia: a prospective cohort study. JAGS 59:1369–1375CrossRef Dublin S, Andrson ML, Haneuse SJ et al (2011) Atrial fibrillation and risk of dementia: a prospective cohort study. JAGS 59:1369–1375CrossRef
52.
Zurück zum Zitat Flaker GC, Pogue J, Yusuf S et al (2010) Cognitive function and anticoagulation control in patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes 3:277–283PubMedCrossRef Flaker GC, Pogue J, Yusuf S et al (2010) Cognitive function and anticoagulation control in patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes 3:277–283PubMedCrossRef
53.
Zurück zum Zitat Jacobs LG, Billett HH, Freeman K et al (2009) Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early stage dementia: a single center, retrospective, observational study. Am J Geriatr Pharamcother 7(3):159–166CrossRef Jacobs LG, Billett HH, Freeman K et al (2009) Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early stage dementia: a single center, retrospective, observational study. Am J Geriatr Pharamcother 7(3):159–166CrossRef
54.
Zurück zum Zitat McCormick D, Gurwitz JH, Goldberg RJ et al (2001) Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting. Arch Intern Med 161:2458–2463PubMedCrossRef McCormick D, Gurwitz JH, Goldberg RJ et al (2001) Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting. Arch Intern Med 161:2458–2463PubMedCrossRef
55.
Zurück zum Zitat Gurwitz JH, Field TS, Radford MJ et al (2007) The safety of warfarin therapy in the nursing home setting. Am J Med 120:539–544PubMedCrossRef Gurwitz JH, Field TS, Radford MJ et al (2007) The safety of warfarin therapy in the nursing home setting. Am J Med 120:539–544PubMedCrossRef
56.
Zurück zum Zitat Papaioannou A, Kennedy CC, Campbell G et al (2010) A team-based approach to warfarin management in long term care: a feasibility study of the MEDeINR electronic decision support system. BMC Geriatr 10:38PubMed Papaioannou A, Kennedy CC, Campbell G et al (2010) A team-based approach to warfarin management in long term care: a feasibility study of the MEDeINR electronic decision support system. BMC Geriatr 10:38PubMed
57.
Zurück zum Zitat Folstein MF, Folstein SE, McHugh PR et al (1975) „Mini-mental state“: a practical method for grading the cognitive status of patients for the clinicians. J Psychiatr Res 12:189–198PubMedCrossRef Folstein MF, Folstein SE, McHugh PR et al (1975) „Mini-mental state“: a practical method for grading the cognitive status of patients for the clinicians. J Psychiatr Res 12:189–198PubMedCrossRef
58.
Zurück zum Zitat Yesavage JA, Brink TL, Rose TL et al (1982) Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 17:37–49PubMedCrossRef Yesavage JA, Brink TL, Rose TL et al (1982) Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 17:37–49PubMedCrossRef
59.
Zurück zum Zitat American Geriatrics Society (2001) Guideline for the prevention of falls in older persons. American Geriatrics Society, British Geriatrics Society, and American Academy of Orthopaedic Surgeons Panel on Falls Prevention. J Am Geriatr Soc 49:664CrossRef American Geriatrics Society (2001) Guideline for the prevention of falls in older persons. American Geriatrics Society, British Geriatrics Society, and American Academy of Orthopaedic Surgeons Panel on Falls Prevention. J Am Geriatr Soc 49:664CrossRef
Metadaten
Titel
Management und Therapie des Vorhofflimmerns beim geriatrischen Patienten
verfasst von
Mag. Dr. M. Gosch, MAS
R.E. Roller
B. Böhmdorfer
U. Benvenuti-Falger
B. Iglseder
M. Lechleitner
U. Sommeregger
P. Dovjak
Publikationsdatum
01.01.2012
Verlag
Springer-Verlag
Erschienen in
Zeitschrift für Gerontologie und Geriatrie / Ausgabe 1/2012
Print ISSN: 0948-6704
Elektronische ISSN: 1435-1269
DOI
https://doi.org/10.1007/s00391-011-0268-0

Weitere Artikel der Ausgabe 1/2012

Zeitschrift für Gerontologie und Geriatrie 1/2012 Zur Ausgabe

Beiträge zum Themenschwerpunkt

A brief update on dementia prevention

Editorial

Vorwort

Mitteilungen der ÖGGG

Mitteilungen der ÖGGG

Beiträge zum Themenschwerpunkt

Palliativversorgung von Menschen mit Demenz

Beiträge zum Themenschwerpunkt

Diabetes und Demenz